Bibliography
1. Snow A, Chen D, Lang JE. The current status of the clinical utility
of liquid biopsies in cancer. Expert Rev Mol Diagn 2019:1-11.
2. Leers MPG. Circulating tumor DNA and their added value in molecular
oncology. Clin Chem Lab Med 2019.
3. Singhal S, Rolfo C, Maksymiuk AW, Tappia PS, Sitar DS, Russo A, et
al. Liquid Biopsy in Lung Cancer Screening: The Contribution of
Metabolomics. Results of A Pilot Study. Cancers (Basel)2019;11 (8).
4. Kwapisz D. The first liquid biopsy test approved. Is it a new era of
mutation testing for non-small cell lung cancer? Ann Transl Med2017;5 (3):46.
5. Blackhall F, Frese KK, Simpson K, Kilgour E, Brady G, Dive C. Will
liquid biopsies improve outcomes for patients with small-cell lung
cancer? Lancet Oncol 2018;19 (9):e470-e481.
6. Pisapia P, Pepe F, Smeraglio R, Russo M, Rocco D, Sgariglia R et al.
Cell free DNA analysis by SiRe. J Thorac Dis2017;9 (Suppl 13):S1383-S1390.
7. Heeke S, Hofman P. EGFR Mutation Analysis in Non-small Cell Lung
Carcinoma from Tissue Samples Using the Fully Automated Idylla™ qPCR
System. Methods Mol Biol 2019;2054 :147-155.
8. Malapelle U, Raez LE, Serrano MJ, Rolfo C, (ISLB) ISoLB. Detection of
epidermal growth factor receptor mutations in circulating tumor DNA:
reviewing BENEFIT clinical trial. J Thorac Dis2018;10 (12):6388-6391.
9. Olmedillas-López S, García-Olmo DC, García-Arranz M, Peiró-Pastor R,
Aguado B, García-Olmo D. Liquid biopsy by NGS: differential presence of
exons (DPE) in cell-free DNA reveals different patterns in metastatic
and nonmetastatic colorectal cancer. Cancer Med2018;7 (5):1706-1716.
10. Pisapia P, Malapelle U, Troncone G. Liquid Biopsy and Lung Cancer.Acta Cytol 2018:1-8.
11. Mayo-de-Las-Casas C, Garzón Ibáñez M, Jordana-Ariza N, García-Peláez
B, Balada-Bel A, Villatoro S, Malapelle U et al MA. An update on liquid
biopsy analysis for diagnostic and monitoring applications in non-small
cell lung cancer. Expert Rev Mol Diagn 2018;18 (1):35-45.
12. Hofman P, Heeke S, Alix-Panabières C, Pantel K. Liquid biopsy in the
era of immune-oncology. Is it ready for prime-time use for cancer
patients? Ann Oncol 2019.
13. Scimia M, Du J, Pepe F, Bianco MA, Russo Spena S et al.. Evaluation
of a novel liquid biopsy-based ColoScape assay for mutational analysis
of colorectal neoplasia and triage of FIT+ patients: a pilot study.J Clin Pathol 2018;71 (12):1123-1126.
14 Rossi G, Ignatiadis M. Promises and Pitfalls of Using Liquid Biopsy
for Precision Medicine.Cancer Res. 2019 Jun 1;79(11):2798-2804. doi:
10.1158/0008-5472.CAN-18-3402. Epub 2019 May 20.